These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21488255)

  • 1. Novel human pathological mutations. Gene symbol: TP53. Disease: Li-Fraumeni syndrome.
    Saxena R; Kohli S; Guleria K; Verma IC
    Hum Genet; 2010 Apr; 127(4):480. PubMed ID: 21488255
    [No Abstract]   [Full Text] [Related]  

  • 2. A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.
    Varley JM; McGown G; Thorncroft M; Cochrane S; Morrison P; Woll P; Kelsey AM; Mitchell EL; Boyle J; Birch JM; Evans DG
    Oncogene; 1996 Jun; 12(11):2437-42. PubMed ID: 8649785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.
    Güran S; Tunca Y; Imirzalioğlu N
    Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
    Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
    Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
    MacGeoch C; Turner G; Bobrow LG; Barnes DM; Bishop DT; Spurr NK
    J Med Genet; 1995 Mar; 32(3):186-90. PubMed ID: 7783166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.
    Varley JM; McGown G; Thorncroft M; Tricker KJ; Teare MD; Santibanez-Koref MF; Martin J; Birch JM; Evans DG
    J Med Genet; 1995 Dec; 32(12):942-5. PubMed ID: 8825920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
    Lee SB; Kim SH; Bell DW; Wahrer DC; Schiripo TA; Jorczak MM; Sgroi DC; Garber JE; Li FP; Nichols KE; Varley JM; Godwin AK; Shannon KM; Harlow E; Haber DA
    Cancer Res; 2001 Nov; 61(22):8062-7. PubMed ID: 11719428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome.
    Ribeiro RC; Rodriguez-Galindo C; Figueiredo BC; Mastellaro MJ; West AN; Kriwacki R; Zambetti GP
    Cancer Lett; 2007 Mar; 247(2):353-5; author reply 356-8. PubMed ID: 16750598
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier.
    Varley JM; Thorncroft M; McGown G; Tricker K; Birch JM; Evans DG
    Cancer Genet Cytogenet; 1996 Aug; 90(1):14-6. PubMed ID: 8780740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
    Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H
    Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
    J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
    Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
    Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
    Kouidou S; Malousi A; Maglaveras N
    Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients.
    Zerdoumi Y; Aury-Landas J; Bonaïti-Pellié C; Derambure C; Sesboüé R; Renaux-Petel M; Frebourg T; Bougeard G; Flaman JM
    Hum Mutat; 2013 Mar; 34(3):453-61. PubMed ID: 23172776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.